Dr Laurie Jane Bleicher, MD | |
3851 Piper St, Suite U-422, Anchorage, AK 99508-6904 | |
(907) 561-2533 | |
Not Available |
Full Name | Dr Laurie Jane Bleicher |
---|---|
Gender | Female |
Speciality | General Surgery |
Experience | 53 Years |
Location | 3851 Piper St, Anchorage, Alaska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1861566143 | NPI | - | NPPES |
MD2038 | Medicaid | AK |
Facility Name | Location | Facility Type |
---|---|---|
Providence Alaska Medical Center | Anchorage, AK | Hospital |
Entity Name | Laurie J Bleicher Md Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1306018106 PECOS PAC ID: 1951489293 Enrollment ID: O20080428000050 |
News Archive
Belief in conspiracy theories about the coronavirus pandemic is not only persistent but also is associated with reluctance to accept a COVID-19 vaccine when one becomes available and to engage in behaviors such as mask-wearing that can prevent its spread, according to researchers at the Annenberg Public Policy Center.
A team of researchers from the Harvard School of Public health (HSPH) and the Children's Hospital in Boston have found that children who spend more time watching TV were more likely to eat more of the calorie-dense, low nutrient foods advertised on television.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
A new type of antibody test is being developed by researchers at Linnaeus University and the bioanalysis company Attana. Compared to the binary antibody tests used today, this rapid test can give more detailed information on how our immune systems react to Covid-19 and other types of viruses and bacteria.
Emerging Healthcare Solutions, Inc. announced today that the Company has signed an option with Regenevita, owner of the right to license Neo Natal Progenitor Cell Expansion Technology in Latin America. The core technology on which the Regenevita technology is based was originally developed by NASA, the National Aeronautics and Space Administration, and was sub-licensed to Regenevita for use with Neo Natal Progenitor Cell Expansion.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Laurie Jane Bleicher, MD 3851 Piper St, Suite U-422, Anchorage, AK 99508-6904 Ph: (907) 561-2533 | Dr Laurie Jane Bleicher, MD 3851 Piper St, Suite U-422, Anchorage, AK 99508-6904 Ph: (907) 561-2533 |
News Archive
Belief in conspiracy theories about the coronavirus pandemic is not only persistent but also is associated with reluctance to accept a COVID-19 vaccine when one becomes available and to engage in behaviors such as mask-wearing that can prevent its spread, according to researchers at the Annenberg Public Policy Center.
A team of researchers from the Harvard School of Public health (HSPH) and the Children's Hospital in Boston have found that children who spend more time watching TV were more likely to eat more of the calorie-dense, low nutrient foods advertised on television.
A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has begun enrolling healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The trial, sponsored by NIH's National Institute of Allergy and Infectious Diseases (NIAID), is the first to test mAb CIS43LS in humans. It aims to enroll up to 73 volunteers aged 18 through 50 years old who have never had malaria.
A new type of antibody test is being developed by researchers at Linnaeus University and the bioanalysis company Attana. Compared to the binary antibody tests used today, this rapid test can give more detailed information on how our immune systems react to Covid-19 and other types of viruses and bacteria.
Emerging Healthcare Solutions, Inc. announced today that the Company has signed an option with Regenevita, owner of the right to license Neo Natal Progenitor Cell Expansion Technology in Latin America. The core technology on which the Regenevita technology is based was originally developed by NASA, the National Aeronautics and Space Administration, and was sub-licensed to Regenevita for use with Neo Natal Progenitor Cell Expansion.
› Verified 2 days ago
Dr. Bijiibaa' K Garrison, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 520-390-8275 | |
Dr. Jeffrey Charles Congdon, MD Surgery Medicare: Medicare Enrolled Practice Location: 2925 Debarr Rd, Anchorage, AK 99508 Phone: 907-257-4869 | |
Kevin Joseph Stange, MD Surgery Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Regina Sutton Chennault, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2751 Debarr Rd, Suite 280a, Anchorage, AK 99508 Phone: 907-222-6888 Fax: 907-222-6884 | |
Mark James Thorndike, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Priya Patel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4001 Laurel St Ste 204, Anchorage, AK 99508 Phone: 907-562-8346 | |
Dr. Madhu Prasad, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2925 Debarr Rd Ste D350, Anchorage, AK 99508 Phone: 907-276-3676 Fax: 907-276-3679 |